Thai PBS Thai PBS
Thailand not eligible to produce generic Molnupiravir anti-viral drug

Thailand not eligible to produce generic Molnupiravir anti-viral drug

14 Sept 03:11 Key points summarised by AI
  • Thailand is ineligible to produce a generic version of Merck's Molnupiravir anti-viral drug due to its classification as an upper-middle income economy by the World Bank.
  • This classification mandates Thailand to purchase the drug directly from Merck, as the Medicine Patent Pool agreement only licenses generic manufacturing to low and middle-income countries.
Read full article
News 1/1
Skip > Skip >